Oct 20, 2023
1:10
For every 10 shares held, investors received 1. The price per share adjusted from $0.27 to $0.03.
The split itself did not change the total investment value.
Talaris Therapeutics, Inc. (TALS) trades on the NASDAQ Global Market in the Biotechnology industry.
Talaris Therapeutics, Inc. company overviewThe latest split shown was on October 20, 2023. It was a 1-for-10 reverse split, so shareholders received 1 share for every 10 they held.
This history records one reverse split, on October 20, 2023.